• UCLA Health
  • myUCLAhealth
  • School of Medicine
Institute of Urologic Oncology

UCLA Institute of Urologic Oncology

Institute of Urologic Oncology
  • About Us
    • Director's Welcome
    • Why Choose the UCLA IUO
    • News and Publications
    • The Wasserman Building
    • Jobs
  • Clinical Programs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • Testicular Cancer
    • Integrated Cancer Program
  • Research Programs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • Clinical Trials
  • For Patients
    • Contact Us
    • Clinical Updates
    • Health Plans and Financial Matters
    • Maps and Directions
    • myUCLAhealth
    • Patient Testimonials
    • Preparing for Surgery
    • Webinars / Videos
  • Fellowship
    • Current Fellows
    • Former Fellows
    • Fellow Testimonials
  • Support the IUO
  • For Healthcare Professionals
  • Expert Team
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Institute of Urologic Oncology

Research Programs

Research Programs

Research Programs

  • Bladder Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Clinical Trials
    • What Is a Clinical Trial?
  • Bladder Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Clinical Trials
  • What Is a Clinical Trial?
  1. Home
  2. Institute of Urologic Oncology
  3. Research Programs
  4. Clinical Trials
  5. A New Study to Test the Effectiveness of a New Drug to Treat Kidney Cancer

A New Study to Test the Effectiveness of a New Drug to Treat Kidney Cancer

Share this

A New Study to Test the Effectiveness of a New Drug to Treat Kidney Cancer (Acceleron A041-04)

Official Title of Study: A Phase 2 Randomized, Double-Blind Study of Dalantercept plus Axitinib Compared to Placebo plus Axitinib in Patients with Advanced Renal Cell Carcinoma 

Objective of the study (lay terms): A new study to test the effectiveness of new cancer drug, Dalantercept, in combination with Axitinib compared to Axitinib alone 

For More Detailed Information, Contact:

  • John K. Lee, MD, Principal Investigator
  • Study Coordinator, 310-794-5418, UCLA Department of Hematology-Oncology
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Add Us to Your Google+ Circles Connect with Us on LinkedIn Follow us on Pinterest Follow us on Flickr Follow us on Sharecare
  • UCLA Health
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Publications
  • Giving
  • Careers
  • Volunteer
  • Privacy Practices
  • Nondiscrimination
  • Emergency
  • Smoke-Free
  • Terms of Use
  • 1-800-UCLA-MD1
  • Maps & Directions
  • Contact Us
  • Report Broken Links
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Add Us to Your Google+ Circles Connect with Us on LinkedIn Follow us on Pinterest Follow us on Flickr Follow us on Sharecare